尿基质金属蛋白酶-7可预测心脏术后严重急性肾损伤及不良结局
该前瞻性多中心两阶段队列研究纳入721例心脏手术患者(第一阶段323例儿童,第二阶段398例成人),分析围术期尿MMP-7及其他损伤标志物。结果显示术后尿MMP-7最高五分位较低五分位的严重AKI比值比在成人为17倍、儿童为36倍,且预测严重AKI的AUC在儿童为0.81、成人为0.76,优于其他标志物和临床模型,并能改善风险重分类。
要点
- 心脏术后尿MMP-7在后续发生严重AKI的患者中于术后6小时内达峰。
- 术后尿MMP-7最高五分位与严重AKI风险显著相关(成人17倍,儿童36倍)。
- 尿MMP-7预测严重AKI的AUC儿童0.81、成人0.76,优于多种现有标志物及临床模型。
核心结论
- 尿MMP-7是心脏手术后严重AKI及不良住院结局的有前景预测标志物。
研究设计与样本
- 前瞻性、多中心、两阶段队列研究,共纳入721例心脏手术患者。
- 第一阶段纳入3个学术医学中心的323例儿童,第二阶段纳入6个中心的398例成人。
- 围术期检测尿MMP-7及其他损伤标志物,严重AKI定义为KDIGO分期2或3期。
主要发现
- 发生严重AKI的患者尿MMP-7水平在术后6小时内达峰。
- 多因素校正后,术后尿MMP-7最高五分位较低五分位的严重AKI比值比在成人为17倍、儿童为36倍。
- 尿MMP-7升高与复合事件(严重AKI、急性透析、住院死亡)风险增加及ICU和住院时间延长相关。
- 预测严重AKI的AUC在儿童为0.81、成人为0.76,优于尿IL-18、血管紧张素原、NGAL、白蛋白肌酐比、TIMP-2·IGFBP-7及临床模型。
- 尿MMP-7较单独临床模型显著改善风险重分类(NRI和IDI)。
临床怎么用
- 心脏术后可监测尿MMP-7以早期识别严重AKI高危患者,辅助风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Urinary matrix metalloproteinase-7 (uMMP-7) levels consistently reflect the activity of intrarenal Wnt/β-catenin, which is activated in AKI models. To test the hypothesis that uMMP-7 is a predictor for severe AKI in patients after cardiac surgery, we performed a prospective, multicenter, two-stage cohort study in 721 patients undergoing cardiac surgery. In stage 1, we enrolled 323 children from three academic medical centers. In stage 2, we enrolled 398 adults at six centers. We analyzed levels of uMMP-7 and other injury biomarkers during the perioperative period. Severe AKI was defined as Kidney Disease Improving Global Outcomes stage 2 or 3. uMMP-7 level peaked within 6 hours after surgery in patients who subsequently developed severe AKI. After multivariate adjustment, the highest quintile of postoperative uMMP-7 level, compared with the lowest quintile, associated with 17-fold (in adults) and 36-fold (in children) higher odds of severe AKI. Elevated uMMP-7 level associated with increased risk of composite events (severe AKI, acute dialysis, and in-hospital death) and longer stay in the intensive care unit and hospital. For predicting severe AKI, uMMP-7 had an area under the receiver operating characteristic curve of 0.81 (in children) and 0.76 (in adults), outperforming urinary IL-18, angiotensinogen, neutrophil gelatinase-associated lipocalin, albumin-to-creatinine ratio, and tissue inhibitor of metalloproteinase-2·IGF-binding protein-7 and the clinical model. uMMP-7 significantly improved risk reclassification over the clinical model alone, as measured by net reclassification improvement and integrated discrimination improvement. In conclusion, uMMP-7 is a promising predictor for severe AKI and poor in-hospital outcomes in patients after cardiac surgery.
引用
- Yang X, Chen C, Teng S, et al. Urinary Matrix Metalloproteinase-7 Predicts Severe AKI and Poor Outcomes after Cardiac Surgery. J Am Soc Nephrol. 2017. PMID: 28698269. doi:10.1681/ASN.2017020142
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。